Frequency fo pertussis in children with prolonged cough

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 4, 2008, Pages 314-319

  Yildirim, Inci ^a   Ceyhan, Mehmet ^a   Kalayci, Omer ^a   Cengiz, Ali Bulent ^a   Secmeer, Gulten ^a   Gur, Deniz ^a   Pelton, Steve ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; COUGHING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; NUCLEIC ACID ANALYSIS; OUTPATIENT CARE; PEDIATRIC HOSPITAL; PERTUSSIS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SERODIAGNOSIS; BLOOD; GENETICS; HOSPITAL; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; TIME; TURKEY (REPUBLIC);

ADOLESCENT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; COUGH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS TOXIN; POLYMERASE CHAIN REACTION; TIME FACTORS; TURKEY; WHOOPING COUGH;

EID: 41349092521     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701689659     Document Type: Article

References (29)

1. De Jongste, JC and Shields, MD. (2003) Cough 2: Chronic cough in children. Thorax, 58, pp. 998-1003.
2. Tan, T., Trindade, E. and Skowronski, D. (2005) Epidemiology of pertussis. Pediatr Infect Dis J, 24, p. S10.
3. Cherry, JD. (2005) The epidemiology of pertussis: A comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics, 115, pp. 1422-1427.
4. Versteegh, FG, Weverling, GJ, Peeters, MF, Wilbrink, B., Schie, MT Veenstra-van and van Leeuwen-Gerritsen, JM (2005) Community acquired pathogens associated with prolonged coughing in children: A prospective cohort study. Clin Microbiol Infect, 11, pp. 801-807.
5. Versteegh, FG, Mertens, PL, de Melker, HE, Roord, JJ, Schellekens, JF and Teunis, PF. (2005) Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect, 133, pp. 737-748.
6. Baron, S., Njamkepo, E., Grimprel, E., Begue, P., Desenclos, JC and Drucker, J. (1998) Epidemiology of pertussis in French hospitals in 1993 and 1994: 30 y after a routine use of vaccination. Pediatr Infect Dis J, 17, pp. 412-418.
7. Senzilet, LD, Halperin, SA, Spika, JS, Alagaratnam, M., Morris, A. and Smith, B. (2001) Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis, 32, pp. 1691-1697.
8. Gilberg, S., Njamkepo, E., Du, C., Partouche, H., Gueirard, P. and Ghasarossian, C. (2002) Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole cell vaccine coverage. J Infect Dis, 186, pp. 415-418.
9. Wright, SW, Edwards, KM, Decker, MD and Zeldin, MH. (1995) Pertussis infection in adults with persistent cough. JAMA, 273, pp. 1044-1046.
10. Heininger, U., Schmidt-Schlapfer, G., Cherry, JD and Stehr, K. (2000) Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics, 105, p. E31.
11. Yaari, E., Yafe-Zimerman, Y., Schwartz, SB, Slater, PE, Shvartzman, P. and Andoren, N. (1999) Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest, 115, pp. 1254-1258.
12. Olin, P., Gustafsson, L. and Rasmussen, F. (1997) Efficacy trial of acellular pertussis vaccines: Technical report trial II, with results of preplanned analysis of efficacy, immunogenicity and safety, Swedish Institute for Infectious Disease Control, Stockholm
13. World Health Organization Department of Vaccines and Biologicals (2001) Geneva
14. Heininger, U., Klich, K., Stehr, K. and Cherry, JD. (1997) Clinical findings in Bordetella pertussis infections: Results of a prospective multicentre surveillance study. Pediatrics, 100, p. E10.
15. Giammanco, A., Chiarini, A., Maple, PA, Andrews, N., Pebody, R. and Gay, N. (2003) European Sero-Epidemiology Network: Standardization of the assay results for pertussis. Vaccine, 22, pp. 112-120.
16. Granstrom, M. and Granstrom, G. (1993) Serological correlates in whooping cough. Vaccine, 11, pp. 445-448.
17. Granstrom, G., Wretlind, B., Salenstedt, CR and Granstrom, M. (1988) Evaluation of serological assays for diagnosis of whooping cough. J Clin Microbiol, 26, pp. 1818-1823.
18. Dez-Domingo, J., Ballester, A., Baldo, JM, Planelles, MV, Villarroya, JV and Alvarez, T. (2004) Incidence of pertussis in persons ≤15 y of age in Valencia, Spain: Seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults. J Infect, 49, pp. 242-247.
19. Cherry, JD. (1999) Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis, 28, p. S112.
20. Cimolai, N., Trombley, C. and O'Neill, D. (1996) Diagnosis of whooping cough: A new era with rapid molecular diagnostics. Pediatr Emerg Care, 12, pp. 91-93.
21. Deeks, S., De, SG, Boulianne, N., Duval, B., Rochette, L. and Dery, P. (1999) Failure of physicians to consider the diagnosis of pertussis in children. Clin Infect Dis, 28, pp. 840-846.
22. Couzigou, C. and Flahault, A. (2003) Is pertussis being considered as a cause of persistent cough among adults?. Eur J Epidemiol, 18, pp. 1013-1015.
23. Franco, E., Giambi, C., Ialacci, R. and Maurici, M. (2004) Pertussis vaccination for adolescents and adults. Expert Opin Biol Ther, 4, pp. 1669-1676.
24. Jenkinson, D. (1988) Duration of effectiveness of pertussis vaccine: evidence from a 10-y community study. Br Med J, 296, pp. 612-614.
25. Olin, P., Hallander, HO, Gustafsson, L., Reizenstein, E. and Storsaeter, J. (2001) How to make sense of pertussis immunogencity data. Clin Infect Dis, 33, p. S288.
26. Gustafsson, L., Hallander, HO, Olin, P., Reizenstein, E. and Storsaeter, J. (1996) A controlled trial of a 2-component acellular, a 5-component acellular, and a whole cell pertussis vaccine. N Engl J Med, 334, pp. 349-355.
27. Bremont, F., Micheau, P., Le, RP, Brouard, J., Pin, I. and Fayon, M. (2001) Aetiology of chronic cough in children: Analysis of 100 cases. Arch Pediatr, 8, pp. 645-649.
28. Hallander, HO. (1999) Microbiological and serological diagnosis of pertussis. Clin Infect Dis, 28, p. S99.
29. Hu, JJ, Lu, CY, Chang, LY, Huang, CH, Chou, CC and Huang, FY (2006) Survey of pertussis in patients with prolonged cough. J Microbiol Immunol Infect, 39, pp. 54-58.